Table 1.
Characteristics of included studies.
| Study ID | Participants | Sample | Intervention | Outcomes | |
|---|---|---|---|---|---|
| (Experimental/Control) | Experimental | Control | |||
| Chen 2017 [4] | non-small-cell lung cancer | 9/8 | cisplatin + gemcitabine + rikkunshito | cisplatin + gemcitabine | ①③④ |
| Yang 2010 [5] | non-Hodgkin's lymphoma | 28/28 | Chemotherapy + ligustrazine | chemotherapy alone | ①②③④ |
| Rong 2012 [6] | middle and late stage tumor | 30/30 | chemotherapy + Dujieqing Oral Liquid | chemotherapy alone | ①②③ |
| Wang 2015 [7] | lung cancer | 62/61 | Chemotherapy + Yiqi Jianpi Recipe |
chemotherapy alone | ③ |
①: disease control rate; ②: objective response rate; ③: bone marrow suppression; ④: gastrointestinal reactions.